April 2011 Volume 7, Issue 4

Volume 7, Issue 4 | April 2011

April 2011

In this Issue

Editor's Focus

Drug Discovery News Placeholder Image

A message for Japan: ‘Ganbare’

Although ddn’s news coverage spans the global drug discovery industry, we don’t often have occasion to report on Asia-based companies, as they rarely pursue large-figure mergers and acquisitions.

Commentary

Drug Discovery News Placeholder Image

Too big to succeed, too entrenched to listen

As I mentioned in a recent column, success begets failure. Individual winners become complacent or drunk with power.
Drug Discovery News Placeholder Image

Guest Commentary: What’s driving the decline in AIDS news coverage?

According to a new study, media coverage of HIV/AIDS fell more than 70 percent in developed countries over the last two decades.

Instruments & Informatics

Drug Discovery News Placeholder Image

Bruker acquires Michrom Bioresources

Michrom’s nanoflow ultra-high performance liquid chromatography system is principal asset driving the deal
Drug Discovery News Placeholder Image

Teaming up to interrogate genes about ADME

Roche and RainDance Technologies join forces in targeted sequencing to advance research into drug metabolism and response
Drug Discovery News Placeholder Image

Talkin’ ’bout my generation

Ingenuity Systems, Covance collaborate to support next-generation sequencing research
Drug Discovery News Placeholder Image

Building next-gen castles in the cloud

Geospiza and NuGEN integrate cloud-based software and sample preparation to accelerate results using next-generation sequencing
Drug Discovery News Placeholder Image

HP aims to speed drug discovery research with inkjet technology

Technology giant Hewlett-Packard Development Co. (HP) recently released a drug research application for the company’s inkjet technology that reportedly enables pharmaceutical companies to more efficiently develop better drugs through vastly more precise dispensing of dosages.
Drug Discovery News Placeholder Image

Agilent advances with acquisitions

Seeking to further its application development and market penetration, Agilent Technologies adds BIOCIUS Life Sciences and Lab901 to its fold

Research & Development

Drug Discovery News Placeholder Image

Coastal cancer collaboration

Gilead Sciences acquires oncology-focused biotech Calistoga Pharmaceuticals for $375 million
Drug Discovery News Placeholder Image

Finding potential cures in the ‘public library’

Scripps and MIT scientists discover class of potent anti-cancer compounds that may also lead to new therapies for Alzheimer's disease patients
Drug Discovery News Placeholder Image

No immunity for autoimmune disease

Merck, Lycera team up to advance program that targets Th17 cells
Drug Discovery News Placeholder Image

The pulse of heart treatment

Nile Therapeutics to collaborate with Medtronic on clinical development of cenderitide for heart failure and renal disease
Drug Discovery News Placeholder Image

HGS, FivePrime ink agreement to develop anti-cancer drug

Human Genome Sciences Inc. (HGS) and FivePrime Therapeutics Inc. announced March 16 that they have entered into an agreement to develop and commercialize FivePrime’s FP-1039 product for multiple cancers.
Drug Discovery News Placeholder Image

UMass Human Stem Cell Bank and Registry partners with U.K. Stem Cell Bank

The University of Massachusetts Human Stem Cell Bank and Registry and the United Kingdom Stem Cell Bank on March 15 signed an agreement to share best practices for stem cell banking and to collaborate on standards for stem cell line characterization, production and distribution in the United States and U.K.
Drug Discovery News Placeholder Image

A Forest grows around it

Forest Laboratories commences $1.2 billion tender offer for all outstanding shares and certain notes and warrants of Clinical Data

Global News

Drug Discovery News Placeholder Image

Japanese pharmas eye opportunities abroad

Kyowa Hakko and Daiichi Sankyo acquisitions of foreign firms total $1.4 billion, signaling that Japanese firms are turning to international M&As for pipeline growth
Drug Discovery News Placeholder Image

Playing a blocking game against tumors

Cancer Research Technology and Institute of Cancer Research sign discovery and development deal with ZoBio
Drug Discovery News Placeholder Image

Organizing with ORIS

IDBS powers personalized cancer care at King’s Health Partners with enterprise translational medicine platform
Drug Discovery News Placeholder Image

A Phenomica partnership

Phenotypic screening of massive peptide library to be launched by drug discovery spinoff
Drug Discovery News Placeholder Image

A future without fat?

Vancouver’s Sirona Biochem to acquire France-based TFChem for technology in treating obesity, diabetes

Contract Services

Drug Discovery News Placeholder Image

Fujifilm focuses on biotech future

Photo media-centric firm snaps up Merck’s contract manufacturing and service subsidiaries Diosynth and MSD Billingham
Drug Discovery News Placeholder Image

Good manufacturing practice

Viropro acquires Alpha Biologics’ biotech GMP production facility and CRO services
Drug Discovery News Placeholder Image

A regulatory affair

Clinipace Worldwide acquires Regulus Pharmaceutical Consulting
Drug Discovery News Placeholder Image

Quality and quantity

QPS increases Asian presence, expands clinical trials with acquisition of majority stake in Taiwan-based Qualitix
Drug Discovery News Placeholder Image

Pearl of the Orient

Bristol-Myers Squibb’s newest ‘String of Pearls’ addition is Chinese outsourcing firm WuXi PharmaTech, which will build a stability testing facility for BMS in China
Drug Discovery News Placeholder Image

Helping a new swimmer in the biopharma pool

Quintiles supports Samsung’s entry into the biopharma market through joint venture and makes minority investment in Samsung biosimilars manufacturing facility

Diagnostics

Drug Discovery News Placeholder Image

Lightening its load

Thermo Fisher Scientific sells Athena Diagnostics to Quest Diagnostics, Lancaster Laboratories to Eurofins in two deals totaling $940 million
Drug Discovery News Placeholder Image

Patient-driven, not disease-driven

Ipsen and bioMérieux form broad therapeutics and diagnostics alliance
Drug Discovery News Placeholder Image

A mutual interest in mutants

Novartis taps Invivoscribe for test to identify FLT3- positive AML patients
Drug Discovery News Placeholder Image

Risk and reward

Mira Dx licenses triple-negative breast cancer risk variant from Yale University
Drug Discovery News Placeholder Image

Test for the weary

Chronix Biomedical and Hemispherx Biopharma join forces to develop diagnostic test for Chronic Fatigue Syndrome

Omics & Systems Biology

Drug Discovery News Placeholder Image

Being PARP of the solution

MDxHealth tapped by Newcastle University, Cancer Research Technology and Pfizer to help develop companion diagnostic for PARP-based ovarian and breast cancer treatment
Drug Discovery News Placeholder Image

Covance, ISB form brain tumor partnership

Researchers to study the genetic differences occurring within glioblastoma multiforme
Drug Discovery News Placeholder Image

Cell therapy collaboration prepares to (fibro) blast off

Fibrocell Science, UCLA announce collaboration aimed at fibroblast research
Drug Discovery News Placeholder Image

Calling ADAM-12

Gene probed by Missouri researchers shows promise for variety of hard-core offenders
Drug Discovery News Placeholder Image

British researchers locate key to early bowel cancer detection

Cancer Research U.K. scientists link DNA methylation patterns to deadly form of cancer

Special Reports

Drug Discovery News Placeholder Image

Drug delivery: Why getting there isn’t half the fun

With evolving dosage forms, the dissolution test is constantly being altered
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue